Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
New Incentives
AddedMar 17, 2024
UpdatedJul 1, 2026
New Incentives

New Incentives

Seed

Empowering Nigerian mothers with life-saving cash transfers.

Accelerator
Y Combinator logoY CombinatorS16
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to save lives through financial incentives, New Incentives focuses on encouraging Nigerian mothers to immunize their infants against deadly diseases. The organization implements cash transfer programs that directly reward mothers for vaccinating their children, aiming to increase immunization rates and improve public health outcomes. By targeting underserved communities in Nigeria, New Incentives addresses both health and economic challenges, ensuring that more children receive essential vaccinations.

Notable figures affiliated with New Incentives include its founders and key health experts who have contributed to its strategic direction. The organization has received support from prominent global health investors and philanthropic entities. Key achievements include significant increases in immunization rates in targeted regions and recognition from health organizations for its innovative approach. Overall, New Incentives has made a substantial impact on public health in Nigeria by combining financial incentives with essential healthcare services.

New Incentives - Similar Companies

Immunity Project logo

Immunity Project

The Centre for Effective Altruism logo

The Centre for Effective Altruism

Incentivize logo

Incentivize

incentivize.us

Incentivyze logo

Incentivyze

incentivyze.com

Covid-19 Innovation Acceleration Fund. logo

Covid-19 Innovation Acceleration Fund.

Givefront logo

Givefront

givefront.com

InstaKin logo

InstaKin

instakin.com

Incentify logo

Incentify

incentify.com

Instrumentl logo

Instrumentl

instrumentl.com

AidBanc logo

AidBanc

aidbanc.com

Johnson & Johnson Impact Ventures logo

Johnson & Johnson Impact Ventures

Rally Tax logo

Rally Tax

goinri.com

New Incentives - Quick Facts

Who are New Incentives' competitors?

Companies similar to New Incentives include Immunity Project, The Centre for Effective Altruism, Incentivize and Incentivyze.

When was New Incentives' last funding round?

New Incentives' most recent funding round was for $120k (USD) in January 2016.

How much has New Incentives raised to-date?

As of Jan 1, 2016, New Incentives has raised a total of $120k (USD).

How many employees does New Incentives have?

New Incentives has 51 employees as of Aug 23, 2023.

New Incentives - Classification

Technology
  • HealthTech
Customer
  • Non-Profit
Main Product
  • Cash Transfers
  • Immunization
Tags
  • Nigeria